FOLH1 and glioblastoma: Yet, a case report on a glioblastoma patient treated with [177Lu]Lu-PSMA showed good tumor tracer retention on post-therapy imaging, resulting in a substantial tumor absorbed dose [53], and in another glioblastoma patient, [177Lu]Lu-PSMA treatment resulted in a decrease in tumor volume [55].